163 related articles for article (PubMed ID: 11786681)
1. Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration.
Kanda F; Okuda S; Matsushita T; Takatani K; Kimura KI; Chihara K
Horm Res; 2001; 56 Suppl 1():24-8. PubMed ID: 11786681
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 1 inhibits glucocorticoid-induced glutamine synthetase activity in cultured L6 rat skeletal muscle cells.
Kimura K; Kanda F; Okuda S; Chihara K
Neurosci Lett; 2001 Apr; 302(2-3):154-6. PubMed ID: 11290410
[TBL] [Abstract][Full Text] [Related]
3. [Steroid-induced myopathy].
Polunina AG; Isaev FV; Dem'ianova MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10 Pt 2):60-4. PubMed ID: 23250613
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy.
Kanda F; Takatani K; Okuda S; Matsushita T; Chihara K
Muscle Nerve; 1999 Feb; 22(2):213-7. PubMed ID: 10024134
[TBL] [Abstract][Full Text] [Related]
5. Can growth hormone counteract the catabolic effects of steroids?
Mauras N
Horm Res; 2009 Nov; 72 Suppl 1():48-54. PubMed ID: 19940496
[TBL] [Abstract][Full Text] [Related]
6. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy.
Dirks-Naylor AJ; Griffiths CL
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):1-7. PubMed ID: 19520160
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1--implications for steroid-induced myopathy.
Inder WJ; Jang C; Obeyesekere VR; Alford FP
Clin Endocrinol (Oxf); 2010 Jul; 73(1):126-32. PubMed ID: 19681914
[TBL] [Abstract][Full Text] [Related]
9. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
Naim MY; Reed AM
J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
[TBL] [Abstract][Full Text] [Related]
10. [Reevaluation of validity of percent creatinuria for diagnosing steroid myopathy].
Shimohata T; Umeda M; Tanaka K; Nishizawa M
No To Shinkei; 2006 Jan; 58(1):39-42. PubMed ID: 16482920
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic work-up in steroid myopathy.
Minetto MA; D'Angelo V; Arvat E; Kesari S
Endocrine; 2018 May; 60(2):219-223. PubMed ID: 29143179
[TBL] [Abstract][Full Text] [Related]
12. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women.
Thompson JL; Butterfield GE; Marcus R; Hintz RL; Van Loan M; Ghiron L; Hoffman AR
J Clin Endocrinol Metab; 1995 Jun; 80(6):1845-52. PubMed ID: 7539817
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects.
Mauras N
Horm Res; 2001; 56 Suppl 1():13-8. PubMed ID: 11786679
[TBL] [Abstract][Full Text] [Related]
14. Role of IGF-I in muscular atrophy of aging.
Borst SE; Lowenthal DT
Endocrine; 1997 Aug; 7(1):61-3. PubMed ID: 9449034
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
Yuen KC; Dunger DB
Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy.
Konno S
Neurochem Res; 2005 May; 30(5):669-75. PubMed ID: 16176071
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced myopathy.
Pereira RM; Freire de Carvalho J
Joint Bone Spine; 2011 Jan; 78(1):41-4. PubMed ID: 20471889
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
19. [Steroid-induced myopathy].
Perrot S; Le Jeunne C
Presse Med; 2012 Apr; 41(4):422-6. PubMed ID: 22326665
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER
J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
